Key Metrics
CiteScore 

0.2
Impact Factor 

< 5
SJR 

Q4Pharmacology

SNIP 

0.06
Recommended pre-submission checks
Powered by 

Topics Covered on Drugs of the Future
Drugs of the Future Journal Specifications
Indexed in the following public directories
Scopus
SJR
| Overview | |
| Publisher | PROUS SCIENCE, SAU-THOMSON REUTERS |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1976 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Drugs of the Future ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Drugs of the Future
American Society of Hematology - 64th Annual Meeting and Exposition. New Orleans - December 10-13, 2022
- 1 Mar 2023
- Drugs of the Future
Pipeline on the Move
- 1 Mar 2023
- Drugs of the Future
Spesolimab. Anti-IL-36R monoclonal antibody, Treatment of generalized pustular psoriasis, Treatment of immune-mediated inflammatory diseases
- 1 Mar 2023
- Drugs of the Future
Recent trends in medicinal chemistry and enabling technologies. Highlights from the Society for Medicines Research Conference. London - December 8, 2022
- 1 Mar 2023
- Drugs of the Future
Tirzepatide. Dual GLP-1/GIP receptor agonist, Treatment of type 2 diabetes and obesity
- 1 Mar 2023
- Drugs of the Future
Bimiralisib. Phosphatidylinositol 3-kinase (PI3K)/mechanistic target of rapamycin (mTOR) inhibitor, Treatment of solid tumors, Treatment of lymphoma
- 1 Mar 2023
- Drugs of the Future
American Society of Hematology - 64th Annual Meeting and Exposition. New Orleans - December 10-13, 2022
- 1 Mar 2023
- Drugs of the Future
Pipeline on the Move
- 1 Mar 2023
- Drugs of the Future
Spesolimab. Anti-IL-36R monoclonal antibody, Treatment of generalized pustular psoriasis, Treatment of immune-mediated inflammatory diseases
- 1 Mar 2023
- Drugs of the Future
Recent trends in medicinal chemistry and enabling technologies. Highlights from the Society for Medicines Research Conference. London - December 8, 2022
- 1 Mar 2023
- Drugs of the Future
Tirzepatide. Dual GLP-1/GIP receptor agonist, Treatment of type 2 diabetes and obesity
- 1 Mar 2023
- Drugs of the Future
Bimiralisib. Phosphatidylinositol 3-kinase (PI3K)/mechanistic target of rapamycin (mTOR) inhibitor, Treatment of solid tumors, Treatment of lymphoma
- 1 Mar 2023
- Drugs of the Future